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Summary
Persistent microvascular hyperpermeability to plasma proteins even after the cessation of injury
is a characteristic but poorly understood feature of normal wound healing. It results in extravasation
offibrinogen that clots to form fibrin, which serves as a provisional matrix and promotes angiogenesis
and scar formation. We present evidence indicating that vascular permeability factor (VPF ; also
known as vascular endothelial growth factor) may be responsible for the hyperpermeable state,
as well as the angiogenesis, that are characteristic of healing wounds . Hyperpermeable blood
vessels were identified in healing split-thickness guinea pig and rat punch biopsy skin wounds
by their capacity to extravasate circulating macromolecular tracers (colloidal carbon, fluoresceinated
dextran) . Vascular permeability was maximal at 2-3 d, but persisted as late as 7 d afterwounding .
Leaky vessels were found initially at the wound edges and later in the subepidermal granulation
tissue as keratinocytes migrated to cover the denuded wound surface. Angiogenesis was also
prominent within this 7-d interval . In situ hybridization revealed that greatly increased amounts
ofVPFmRNA were expressed by keratinocytes, initially those at the wound edge, and, at later
intervals, keratinocytes that migrated to cover the wound surface; occasional mononuclear cells
also expressed VPFmRNA . SecretedVPF was detected by immunofluoroassay ofmedium from
cultured human keratinocytes. These data identify keratinocytes as an important source ofVPF
gene transcript and protein, correlateVPF expression with persistent vascular hyperpermeability
and angiogenesis, and suggest that VPF is an important cytokine in wound healing .
W
ound healing is a well-ordered response to injury
characterized by diverse cellular activities that include
acute and chronic inflammation, cell migration, angiogen-
esis, and matrix deposition (1-3) . The initial wounding event
injures blood vessels and results in focal hemorrhage. Fibrino-
gen in extravasated blood clots to form a fibrin gel into which
other plasma proteins, notably fibronectin, may be incorpo-
rated (4) . Inflammatory cells, fibroblasts, andnew blood vessels
migrate into this gel, digesting it while depositing cellular
fibronectins, interstitial collagens, proteoglycans, and other
components of mature stroma (2) . In this manner, the provi-
sional fibrin matrix is replaced by granulation tissue, and later,
by a scar. Coincident with stroma generation, keratinocytes
migrate to provide an epidermal covering that prevents fluid
loss and retards bacterial invasion . This ordered sequence of
events is thought to be orchestrated by interactions among
cells, growth factors (e.g ., platelet-derived growth factor,
TGF-(3, basic fibroblast growth factor), and extracellular ma-
trix proteins (5) .
A poorly appreciated feature ofwound healing is that vas-
cular hyperpermeability continues at wound sites for a con-
siderable time after the cessation of overt bleeding (6, 7) . Thus,
vessels continue to leak plasma proteins for several days after
the initiating trauma has ceased and even for a short time
after a complete epidermal covering has been restored . Con-
tinued vascular hyperpermeability results in persistent extrava-
sation of fibrinogen and ongoing deposition of provisional
fibrin gel matrix, events that favor the continued induction
of granulation tissue . The mechanisms responsible for initi-
ating and maintaining the persistent vascular hyperpermea-
bility characteristic of healing wounds have not been inves-
tigated .
Previously, our laboratory and others have described a pro-
tein, vascular permeability factor (VPF),' that enhances the
permeability of local venules and small veins with a potency
1 Abbreviations used in this paper: VEGF, vascular endothelial growth factor;
VPF, vascular permeability factor.
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selective mitogen for endothelial cel-Is, hence, its alternative
name, vascular endothelial growth factor (VEGF) (10, 11),
andhas been reported to be chemotactic for monocytes (12) .
Since increased vascular permeability and angiogenesis are char-
acteristic features of wound healing (3), we considered the
possibility that this mediator might also be present in healing
wounds.
Materials and Methods
Wounding and Preparation of Tissuefor Histology and In Situ Hy-
bridization. Partial thickness skin wounds were boredwith a 4-mm
biopsy punch on the shaved flanks of young adult female CD rats
(200-250 g; Charles River Breeding Laboratories, Inc ., Wilmington,
MA) or strain 2 guinea pigs (500-600 g; National Cancer Insti-
tute, Bethesda, MD) anesthetized with 25 mg/kg ketamine HCl
and 5 mg/kg xylazine. At various intervals afterwounding, animals
were killed by ether/carbon dioxide inhalation and tissues were
processed for in situ hybridization (13, 14) . All animal procedures
had the approval of theBeth Israel Hospital Institutional Animal
Care and Use Committee .
To assess vascular permeability, wound-bearing rats were injected
intravenously with either colloidal carbon (0 .5 cc/250 g ; Gunther
Wagner, Inc.) or 70-kD fluoresceinated FITC-dextran (2 p.mol or
144 mg/250 g; Sigma Chemical Co., St . Louis, MO), and killed
70 or 30 min, respectively, after injection . Tissues from carbon-
injected animals were fixed in paraformaldehyde-glutaraldehyde for
preparation of 1 p,m Epon sections ; tissues from FITC-dextran-
injected animals were fixed in70%ethanol-formaldehyde for paraffin
sections (15) .
In Situ Hybridization.
￿
Rat cDNA for VPF was prepared using
PCR as described previously (13), except that a different reverse
primer(CCGGAATTCAGCGCCTCGGCTTGTC)was used . The
resulting cDNA (393 bp) was subdoned into pGEM-3Zf(+)
(Promega Biotec, Madison, WI), from which single-stranded an-
tisense RNA probes were synthesized (N10a cpm/ttg) with 35S-
UTP, purified on polyacrylamide gels, and used without reduction
in length . This probe contains sequences common to all four of
the VPF isoforms thus far described (16, 17) . A probe of the same
length but in the sense orientation served as acontrol . In situ hy-
bridization on guinea pig wounds and human keratinocytes was
carried out with probes to guinea pig and human VPF as previ-
ously described (13) . These probes reactedboth with a 4.5-kbband
on Northern blots and with mRNA in tissue sections from the
respective species (13) .
Keratinocyte CultureandImmunoassayofVPF .
￿
Humanepidermal
keratinocytes (Clonetics, Inc ., San Diego, CA) were maintained
for two to four passages in serum-free keratinocyte growth medium
(KGM ; Clonetics, Inc.) at 37°C, 5% COZ . For VPF quantitation,
cells were subcultured in 24-well plates (Costar, Cambridge, MA)
at 42,000 cells per well, and, after overnight culture, medium (1
ml) was replaced with freshKGM. At varying intervals thereafter,
the conditionedmedium was harvestedand the cell layer extracted
with 0.5 ml lysis buffer (0.5% Triton X-100 in PBS, pH 7.2,
containing 0.24 TIU/ml aprotinin) . Samples were centrifuged
(10,000 g, 4°C) and stored (-70°C) for immunoassay. Replicate
50-pl samples of human keratinocyte culture media were assayed
forVPF in a time-resolved immunofluorometric assay as previously
described (18) . Affinity-purified polyclonal rabbit antibodies directed
against the COON-terminal region of guinea pig VPF served as
the "capture" antibodies. Affinity-purified polyclonal rabbit anti-
bodies prepared against a peptide corresponding to theNH 2 ter-
minus of human VPF (8) were covalently linked to Eu3 + chelate
to permit fluorometric detection as second antibodies (18) . Results
of the immunoassay of conditioned medium were normalized for
total cell protein as determined by theBCA assay (Pierce Chemical
Co., Rockland, IL) . Recombinant human VPF served as a stan-
dard (gift ofDr. Steven Ledbetter, Upjohn Laboratories, Kalamazoo,
MI) to quantitate the VPF secreted by human keratinocytes .
Results and Discussion
Rat and guinea pig skin wounds healed with similar ki-
netics in accord with prior descriptions (14, 19) . Within
minutes ofpunchbiopsy the wound defect was filled by clotted
blood and bleeding stopped . Tracer studies with either col-
loidal carbon or 70-kD FITC-D confirmed earlier reports that
significant vascular hyperpermeability persisted for some days
afterwounding in both rat andguinea pig skin (6) and local-
ized leakage to specific blood vessels that most closelyresem-
bled venules and small veins (Fig. 1, A-F) . With both tracers,
extensive leakage wasevident in 2-3-dwounds (Fig. 1,A-C),
and vascular hyperpermeability persisted at decreasing levels
through day 7 (Fig. 1, D-F) . Leaky vessels were located in
the superficial dermis at the wound edges (Fig . 1,D andE)
and more centrally in the granulation tissue of the wound
bed (Fig . 1, A-C and F) . The endothelial cells lining hyper-
permeable vessels were enlarged and occasionally exhibited
mitotic figures, indicating that they were participating in the
angiogenic response (Fig. 1, A, B, andD-F) ; thus, an exten-
sive temporal and spatial overlapping ofvascular hyperperme-
ability and angiogenesis occurred .
Preliminary experiments, using a time-resolved immuno-
fluorometric assay (18), indicated that VPF protein was de-
tectable in wound extracts . In situ hybridization was then
performed to define the cellular source(s) ofthe VPF expressed
in rat and guinea pig healing wounds, and identical results
were obtained with both species usingthe appropriate probes .
Antisense probes revealed strikingly elevated VPF mRNA
in keratinocytes at the wound edges as early as 1 d after
wounding, and abundant VPF expression was a prominent
Figure 1 .
￿
Vascular hyperpermeability and in situ expression of VPF mRNA in healing rat (A, B, andD-J) and guinea pig (C) skin wounds . (A-C)
Leaky vessels (v) present in early granulation tissue underlying 3-d rat (A and B) or guinea pig (C) skin wounds as detected by colloidal carbon (A
and B) or 70-kD FITC-D (C) extravasation . Arrows (A and B) indicate carbon deposited in vessel walls . (D and E) Filled arrows identify colloidal
carbon deposits in vessels of a 5-d wound; one of these (v) contains a mitotic endothelial cell (open arrow) and is illustrated at higher magnification
in E . Note proximity of these leaky vessels to the junction between wound epidermis (e', right) and normal epidermis (e, left), a distinction made
obvious by different staining properties . (F) A persistent carbon-labeled vessel (arrows) underlying newly migrated epidermis covering a 7-d wound .
(GJ) In situ hybridization of 3-d (G andj) and 7-d (17) rat skin wounds and normal skin adjacent to a 3-d wound (1) hybridized with a 35S-labeled
antisense probe to VPF . (G) Strong keratinocyte labeling is observed throughout the thickened epidermis (e') that is proliferating and migrating to
cover the wound defect ; by contrast, the epidermis (e) of nearby normal skin is unlabeled (1) . Rare mononuclear cells, probably macrophages (arrows),
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Vascular Permeability Factor Expression by Wound Keratinocytesin the 3-d wound bed (J) are also strongly labeled . In 7-d wounds (H), epidermal (e') thickening persists but keratinocyte labeling for VPF mRNA
has decreased markedly, though still remaining above background levels. (A, B, and D-F) 1-Pm thick, Giemsa stained, Epon sections; (C) fluorescence
microscopy of unstained, 20-Am paraffin section . (G-H) Hematoxylin and eosin sections of radioautographs viewed by combined epipolarization and
low light level bright field microscopy. (A and B) x1,100 ; (C and D) x360 ; (E) x850 ; (F) x680 ; (G-1) x260 ; (J) x430.
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the wound defect . Epidermal labeling was maximal on days
2-3, and keratinocytes of the basal and the more superficial,
differentiated layers expressed VPF mRNA with equal in-
tensity (Figs. 1 G and 2A) . By day 7, when epidermal covering
was complete, keratinocyte expression of VPF mRNA per-
sisted at above normal levels (Fig. 1,H vs . I), though inmuch
lower amounts than at earlier stages of wound healing . In
addition to keratinocytes, occasional mononuclear cells with
morphological features of macrophages in the wound bed
also expressedVPFmRNA (Fig. 1J) . Neither keratinocytes,
macrophages, nor any other cell type in rat or guinea pig
wounds or in normal skin labeled with sense riboprobes (Fig.
2 B) . To obtain independent evidence that keratinocytes syn-
thesize and secrete VPF, immunoassays were performed on
isolated human keratinocytes. The immunofluorometric assay
used for these experiments employs an antipeptide antibody
directed to the COOH terminus of VPF as the "capture"
antibody and a second antipeptide antibody to the NH2 ter-
minus ofVPF as the "reporter" antibody (18) . Using this
assay, we found that human keratinocytes (42,000 per well)
cultured in serum-freemedium for 120 h secreted ti6ngVPF.
Using a human VPF probe, we also carried out in situ hy-
bridization on cellsgrown under these conditions and demon-
strated the presence ofVPF mRNA . These results demon-
strate that the VPF gene is transcribed and that VPF is
synthesized and secreted by cultured keratinocytes.
Taken together, these data indicate thatVPF and itsmRNA
are expressed in normal keratinocytes, both in situ and in
tissue culture, and thatVPF expression is markedly increased
in the activated, migrating keratinocytes involved in wound
healing. Occasional mononuclear cells, probably macrophages,
in the wound bed also expressed VPF mRNA . This VPF
expression is likely to have important biological significance
because vessels exhibiting increased permeability were in close
proximity (<0.5 mm) to VPF-expressing keratinocytes and/or
macrophages, and the time course of VPF mRNA expres-
sion, microvascular hyperpermeability, and angiogenesis over-
lapped. VPF may be expected to induce angiogenesis in two
ways : directly by serving as an endothelial cell mitogen, and
indirectly by increasing vascular hyperpermeability and thereby
promoting the deposition of an extravascular fibrin matrix,
which is itself a potent angiogenic stimulus (20) . Keratino-
cytes have increasingly come to be recognized as important
regulators of inflammation as they have been found to con-
tain and to express cytokines that promote chemotaxis, acti-
vate macrophages and bonemarrow elements, and induce lym-
phocyte homing (21-23) . The interplay between VPF and
these other cytokines inwound healing now requires investi-
gation .
Figure 2 .
￿
In situ hybridization of keratinocyte layer at edge of a 3-d rat skin wound hybridized with 35S-RNA antisense (A, strongly positive) and
sense (B, negative) VPF probes .
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